This study provides data for the US in vitro diagnostics (IVD) market. Hematology, hemostasis (coagulation), urinalysis, microbiology, clinical chemistry, point of care testing, molecular diagnostics, tissue diagnostics, self-monitoring blood glucose, and immunochemistry are the segments in this market. Market revenues have been included in this deliverable. Additional data and analyses are available for urinalysis, hematology, and hemostasis in the US, Western European, and Russian and Eastern European markets in separate deliverables. There are also separate deliverables looking at the Western European, Russian, and Eastern European IVD market.